A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders
Medvedev VE, Tereshchenko ON, Israelian AIu, et al. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova 2014;114:17-22.
What it found
In patients with phobic, anxiety and somatoform disorders, Selank was reported to have a marked anti-anxiety effect and a mild cognitive effect, lasting a week after the last dose, and to improve quality of life.
Limitations
Article in Russian. The abstract gives no numbers for the comparison with phenazepam and does not describe randomisation or blinding. Co-authored by researchers involved in developing Selank.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.